Health care stocks fell Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 1%.
The iShares Biotechnology ETF (IBB) was down 0.9%.
In corporate news, Protara Therapeutics (TARA) shares surged 85% after the company said its investigational therapy TARA-002 showed a complete response rate of 72% at six months in a phase 2 trial involving people with non-muscle invasive bladder cancer.
Novo Nordisk (NVO) said Thursday it plans to significantly reduce the list price paid by US customers for its Tresiba and Fiasp insulin products starting January 2026. Its shares eased 0.2%.
Nano-X Imaging (NNOX) shares popped 2.4% after the company said it received 510(k) clearance from the US Food and Drug Administration for its Nanox.ARC stationary X-ray system.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。